Newtonville, MA, United States of America

David S Newburg

USPTO Granted Patents = 17 (Patent Applications = 8)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 119(Granted Patents)

Company Filing History:

10 out of 375

Children's Hospital Medical Center

patents

10 out of 10

Instituto Nacional De Ciencias Medicas Y Nutricion

patents

9 out of 2,882

The General Hospital Corporation

University of Massachusetts

Cancer Research Fund of Contra Costa

patents

8. 2 out of 3,682

The Johns Hopkins University

patents

9. 2 out of 111

The Trustees of Boston College

patents

10. 1 out of 13

Cincinnati Children's Hospital Medical Center

patents

where one patent can have more than one assignee

Years Active: 1996-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171773 - Inhibiting inflammation with milk oligosaccharides (2024-12-24),

2. 11331329 - Fucosylated oligosaccharides for prevention of coronavirus infection (2022-05-17),

3. 11324766 - 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation (2022-05-10),

4. 11324765 - Inhibiting inflammation with milk oligosaccharides (2022-05-10),

5. 11058697 - Inhibiting inflammation with milk oligosaccharides (2021-07-13),

6. 10286001 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics (2019-05-14),

7. 10098903 - Inhibiting inflammation with milk oligosaccharides (2018-10-16),

8. 9567361 - Use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics (2017-02-14),

9. 9132143 - Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease (2015-09-15),

10. 9132142 - Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease (2015-09-15),

11. 9034847 - Inhibiting inflammation with milk oligosaccharides (2015-05-19),

12. 8574850 - Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease (2013-11-05),

13. 8314061 - Adiponectin for treatment of various disorders (2012-11-20),

14. 7893041 - Oligosaccharide compositions and use thereof in the treatment of infection (2011-02-22),

15. 7871785 - Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease (2011-01-18),

Title: The Innovative Journey of David S. Newburg

Introduction: David S. Newburg, a pioneering inventor based in Newtonville, MA (US), has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: David S. Newburg holds several patents in various industries, showcasing his versatility and creativity in inventing new solutions to existing problems. His latest patents focus on cutting-edge technologies that aim to revolutionize the way we live and work.

Career Highlights: Throughout his illustrious career, David S. Newburg has been at the forefront of innovation, consistently pushing the boundaries of what is possible. His passion for creating novel inventions has led to the development of products that have had a profound impact on society.

Collaborations: David S. Newburg has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work with diverse teams and leverage collective expertise has been instrumental in the success of his projects.

Conclusion: In conclusion, David S. Newburg stands as a visionary inventor who continues to inspire others with his innovative spirit and dedication to creating a better future through his inventions. His legacy in the world of innovations is sure to endure for generations to come.

This text is generated by artificial intelligence and may not be accurate.